The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

280 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The predictive scores for gastric cancer in gastric intestinal metaplasia(GIM) patient: a recommendation for Thai population.

Objective:

To evaluate major risk factors for gastric cancer in gastric intestinal metaplasia(GIM) patient in order to propose the appropriate recommendation for Thai people.

Research Design:

Single center, retrospective-cohort study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.

NCT05459428

Intestinal Metaplasia of Gastric Mucosa Confocal Laser Endomicroscopy

UNKNOWN

The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM)

NCT01491724

Gastric Intestinal Metaplasia

UNKNOWN

The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM

NCT02932735

Probe-based Confocal Laser Endomicroscopy the Operative Link on Gastric Intestinal Metaplasia

UNKNOWN

Magnified Intelligence Chromoendoscopy Plus Probe-based Confocal Laser Endomicroscopy for Gastric Intestinal Metaplasia Diagnosis

NCT01489397

Gastric Intestinal Metaplasia

COMPLETED NA

AI in GIM Diagnosis

NCT04358198

GIM Diagnosis Artificial Intellegence

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study population and Sample size at Faculty of Medicine, Chulalongkorn University The patients who were diagnosed gastric intestinal metaplasia from 1997 to 2012 and then follow up for 5 years. Estimate sample size =280

* Investigational product, dosage \& route of administration
* Questionnaire for explore the risk factors
* EGD with biopsy
* Blood sampling for gastro panel
* Duration of participation
* 5 years or until diagnose gastric cancer

Statistical method:

Unconditional-binary-logistic regression

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Intestinal Metaplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gastric intestinal metaplasia patient

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All patients were diagnosed GIM
2. All patients have to sign the consent form

Exclusion Criteria

1. Previous gastric surgery including gastrectomy and bypass surgery
2. Bleeding tendency including decompensated cirrhosis, chronic kidney disease and long-tem antiplatelets or anticoagulants
3. HIV infection
4. History of proton pump inhibitor use within 1 week
5. History of antibiotic use within 4 weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No